PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling

Molecular and Cellular Biology

Volumn 34, Issue 6, 2014, Pages 926-938

  Lee, Gha Young ^a   Jang, Hagoon ^a   Lee, Jae Ho ^a   Huh, Jin Young ^a   Choi, Sekyu ^a,b   Chung, Jongkyeong ^a   Kim, Jae Bum ^a  

^a Seoul National University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FASTING; HEPATOCYTES; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PHOSPHORYLATION; PROTEIN INHIBITORS OF ACTIVATED STAT; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84894241362     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01166-13     Document Type: Article

References (50)

1. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187-197.
2. Horton JD, Shimomura I. 1999. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10:143-150. http://dx.doi.org/10.1097/00041433-199904000-00008.
3. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:1125-1131. http://dx.doi.org/10.1172/JCI15593.
4. Jeon TI, Osborne TF. 2012. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23:65-72. http://dx.doi.org/10.1016/j.tem.2011.10.004.
5. Brown MS, Goldstein JL. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340. http://dx.doi.org/10.1016/S0092-8674(00)80213-5.
6. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. 1993. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13:4753-4759.
7. Kim JB, Spiegelman BM. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10:1096-1107. http://dx.doi.org/10.1101/gad.10.9.1096.
8. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77:53-62. http://dx.doi.org/10.1016/0092-8674(94)90234-8.
9. Brown MS, Goldstein JL. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U. S. A. 96:11041-11048. http://dx.doi.org/10.1073/pnas.96.20.11041.
10. Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL. 1996. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 85:1037-1046. http://dx.doi.org/10.1016/S0092-8674(00)81304-5.
11. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U. S. A. 100:12027-12032. http://dx.doi.org/10.1073/pnas.1534923100.
12. Horton JD, Bashmakov Y, Shimomura I, Shimano H. 1998. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. U. S. A. 95:5987-5992. http://dx.doi.org/10.1073/pnas.95.11.5987.
13. Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB, Spiegelman BM. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101:1-9. http://dx.doi.org/10.1172/JCI1411.
14. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F. 1999. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19:3760-3768.
15. Azzout-Marniche D, Becard D, Guichard C, Foretz M, Ferre P, Foufelle F. 2000. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem. J. 350(Pt 2):389-393. http://dx.doi.org/10.1042/0264-6021:3500389.
16. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6:77-86. http://dx.doi.org/10.1016/S1097-2765(05)00010-9.
17. Laplante M, Sabatini DM. 2010. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 107:3281-3282. http://dx.doi.org/10.1073/pnas.1000323107.
18. Wan M, Leavens KF, Saleh D, Easton RM, Guertin DA, Peterson TR, Kaestner KH, Sabatini DM, Birnbaum MJ. 2011. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab. 14:516-527. http://dx.doi.org/10.1016/j.cmet.2011.09.001.
19. Wang Y, Wong RH, Tang T, Hudak CS, Yang D, Duncan RE, Sul HS. 2013. Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin. Mol. Cell 49:283-297. http://dx.doi.org/10.1016/j.molcel.2012.10.028.
20. Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y, Yang ES, Liu LP, Vaitheesvaran B, Bridges L, Kurland IJ, Strich R, Ni JQ, Wang C, Ericsson J, Pessin JE, Ji JY, Yang F. 2012. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J. Clin. Invest. 122:2417-2427. http://dx.doi.org/10.1172/JCI61462.
21. Foretz M, Guichard C, Ferre P, Foufelle F. 1999. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U. S. A. 96:12737-12742. http://dx.doi.org/10.1073/pnas.96.22.12737.
22. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N. 1999. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274:35832-35839. http://dx.doi.org/10.1074/jbc.274.50.35832.
23. Lu M, Shyy JY. 2006. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. Cell Physiol. 290: C1477-C1486. http://dx.doi.org/10.1152/ajpcell.00374.2005.
24. Yellaturu CR, Deng X, Cagen LM, Wilcox HG, Park EA, Raghow R, Elam MB. 2005. Posttranslational processing of SREBP-1 in rat hepatocytes is regulated by insulin and cAMP. Biochem. Biophys. Res. Commun. 332:174-180. http://dx.doi.org/10.1016/j.bbrc.2005.04.112.
25. Hay RT. 2005. SUMO: a history of modification. Mol. Cell 18:1-12. http://dx.doi.org/10.1016/j.molcel.2005.03.012.
26. Gill G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18:2046-2059. http://dx.doi.org/10.1101/gad.1214604.
27. Shuai K, Liu B. 2005. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5:593-605. http://dx.doi.org/10.1038/nri1667.
28. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805. http://dx.doi.org/10.1126/science.278.5344.1803.
29. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. 2000. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:13321-13329. http://dx.doi.org/10.1074/jbc.275.18.13321.
30. Miyauchi Y, Yogosawa S, Honda R, Nishida T, Yasuda H. 2002. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 277:50131-50136. http://dx.doi.org/10.1074/jbc.M208319200.
31. Subramanian L, Benson MD, Iniguez-Lluhi JA. 2003. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278:9134-9141. http://dx.doi.org/10.1074/jbc.M210440200.
32. Lee YS, Sohn DH, Han D, Lee HW, Seong RH, Kim JB. 2007. Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression. Mol. Cell. Biol. 27:438-452. http://dx.doi.org/10.1128/MCB.00490-06.
33. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95:2509-2514. http://dx.doi.org/10.1073/pnas.95.5.2509.
34. Kim KH, Lee GY, Kim JI, Ham M, Won Lee J, Kim JB. 2010. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J. Lipid Res. 51:3425-3433. http://dx.doi.org/10.1194/jlr.M007989.
35. Kim JH, Park KC, Chung SS, Bang O, Chung CH. 2003. Deubiquitinating enzymes as cellular regulators. J. Biochem. 134:9-18. http://dx.doi.org/10.1093/jb/mvg107.
36. Rodriguez MS, Dargemont C, Hay RT. 2001. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:12654-12659. http://dx.doi.org/10.1074/jbc.M009476200.
37. Mukhopadhyay D, Dasso M. 2007. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32:286-295. http://dx.doi.org/10.1016/j.tibs.2007.05.002.
38. Hay RT. 2007. SUMO-specific proteases: a twist in the tail. Trends Cell Biol. 17:370-376. http://dx.doi.org/10.1016/j.tcb.2007.08.002.
39. Hirano Y, Yoshida M, Shimizu M, Sato R. 2001. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J. Biol. Chem. 276:36431-36437. http://dx.doi.org/10.1074/jbc.M105200200.
40. Mohideen F, Capili AD, Bilimoria PM, Yamada T, Bonni A, Lima CD. 2009. A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9. Nat. Struct. Mol. Biol. 16:945-952. http://dx.doi.org/10.1038/nsmb.1648.
41. Yang XJ, Gregoire S. 2006. A recurrent phospho-sumoyl switch in transcriptional repression and beyond. Mol. Cell 23:779-786. http://dx.doi.org/10.1016/j.molcel.2006.08.009.
42. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, Ferre P, Foufelle F. 2009. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119:1201-1215. http://dx.doi.org/10.1172/JCI37007.
43. Pourcet B, Pineda-Torra I, Derudas B, Staels B, Glineur C. 2010. SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J. Biol. Chem. 285:5983-5992. http://dx.doi.org/10.1074/jbc.M109.078311.
44. Rubio T, Vernia S, Sanz P. 2013. Sumoylation of AMPKbeta2 subunit enhances AMP-activated protein kinase activity. Mol. Biol. Cell 24:1801-1811. http://dx.doi.org/10.1091/mbc.E12-11-0806.
45. Sun L, Li H, Chen J, Dehennaut V, Zhao Y, Yang Y, Iwasaki Y, Kahn-Perles B, Leprince D, Chen Q, Shen A, Xu Y. 2013. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J. Natl. Cancer Inst. 105:887-898. http://dx.doi.org/10.1093/jnci/djt118.
46. Arito M, Horiba T, Hachimura S, Inoue J, Sato R. 2008. Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis. J. Biol. Chem. 283:15224-15231. http://dx.doi.org/10.1074/jbc.M800910200.
47. Hirano Y, Murata S, Tanaka K, Shimizu M, Sato R. 2003. Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway. J. Biol. Chem. 278:16809-16819. http://dx.doi.org/10.1074/jbc.M212448200.
48. Giandomenico V, Simonsson M, Gronroos E, Ericsson J. 2003. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol. Cell. Biol. 23:2587-2599. http://dx.doi.org/10.1128/MCB.23.7.2587-2599.2003.
49. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, Zang M, Wu SY, Chiang CM, Veenstra TD, Kemper JK. 2010. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285:33959-33970. http://dx.doi.org/10.1074/jbc.M110.122978.
50. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, Boss O, Hirsch ML, Ribich S, Smith JJ, Israelian K, Westphal CH, Rodgers JT, Shioda T, Elson SL, Mulligan P, Najafi-Shoushtari H, Black JC, Thakur JK, Kadyk LC, Whetstine JR, Mostoslavsky R, Puigserver P, Li X, Dyson NJ, Hart AC, Naar AM. 2010. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. 24:1403-1417. http://dx.doi.org/10.1101/gad.1901210.